DE69635856D1 - Antigenische ha-2 peptide - Google Patents

Antigenische ha-2 peptide

Info

Publication number
DE69635856D1
DE69635856D1 DE69635856T DE69635856T DE69635856D1 DE 69635856 D1 DE69635856 D1 DE 69635856D1 DE 69635856 T DE69635856 T DE 69635856T DE 69635856 T DE69635856 T DE 69635856T DE 69635856 D1 DE69635856 D1 DE 69635856D1
Authority
DE
Germany
Prior art keywords
peptide
minor
peptides
antigen
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635856T
Other languages
English (en)
Other versions
DE69635856T2 (de
Inventor
A Goulmy
F Hunt
H Engelhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
University of Virginia UVA
Original Assignee
Universiteit Leiden
University of Virginia UVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden, University of Virginia UVA filed Critical Universiteit Leiden
Application granted granted Critical
Publication of DE69635856D1 publication Critical patent/DE69635856D1/de
Publication of DE69635856T2 publication Critical patent/DE69635856T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69635856T 1995-07-25 1996-04-25 Antigenische ha-2 peptide Expired - Fee Related DE69635856T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95202039 1995-07-25
EP95202039 1995-07-25
PCT/NL1996/000183 WO1997005169A1 (en) 1995-07-25 1996-04-25 Ha-2 antigenic peptide

Publications (2)

Publication Number Publication Date
DE69635856D1 true DE69635856D1 (de) 2006-04-27
DE69635856T2 DE69635856T2 (de) 2006-11-16

Family

ID=8220530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635856T Expired - Fee Related DE69635856T2 (de) 1995-07-25 1996-04-25 Antigenische ha-2 peptide

Country Status (11)

Country Link
EP (1) EP0840750B1 (de)
JP (1) JPH11514340A (de)
AT (1) ATE318842T1 (de)
AU (1) AU716907B2 (de)
CA (1) CA2224909A1 (de)
DE (1) DE69635856T2 (de)
DK (1) DK0840750T3 (de)
ES (1) ES2259181T3 (de)
NZ (1) NZ305959A (de)
PT (1) PT840750E (de)
WO (1) WO1997005169A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT996636E (pt) 1997-07-23 2005-05-31 Univ Leiden Antigenio ha-1
EP1020519A1 (de) * 1999-01-15 2000-07-19 Introgene B.V. Nebenhistokompatibilitätsantigene, und deren Verwendung zur Diagnose und Behandlung von Tumoren
DK1512014T3 (da) * 2002-06-13 2009-10-05 Merck Patent Gmbh Fremgangsmåder til identifikation af alloantigener samt anvendelse deraf til cancerbehandling og transplantation

Also Published As

Publication number Publication date
EP0840750B1 (de) 2006-03-01
DK0840750T3 (da) 2006-07-03
DE69635856T2 (de) 2006-11-16
AU716907B2 (en) 2000-03-09
EP0840750A1 (de) 1998-05-13
PT840750E (pt) 2006-07-31
ES2259181T3 (es) 2006-09-16
ATE318842T1 (de) 2006-03-15
WO1997005169A1 (en) 1997-02-13
AU5409996A (en) 1997-02-26
JPH11514340A (ja) 1999-12-07
CA2224909A1 (en) 1997-02-13
NZ305959A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
PT900380E (pt) Metodos para seleccionar e produzir epitopos peptidicos de celulas t e vacinas que incorporam os referidos epitopos seleccionados
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
DE69840383D1 (de) Ctl epitope des epstein-barr virus
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
GB2255093A (en) Hiv-1 core protein fragments
Cole et al. Interactions of mycoplasmas and their products with lymphoid cells in vitro
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
IL109790A0 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
ATE318842T1 (de) Antigenische ha-2 peptide
PT996636E (pt) Antigenio ha-1
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
NO942360L (no) Vaksine og polypeptider som er nyttige for denne
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
GB2314560A (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
AR003102A1 (es) Vacuna de env-glicoproteina para la proteccion de infeccion de htlv-i y ii

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee